Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Usefulness of pT1 substaging in papillary urothelial bladder carcinoma.
Patriarca C, Hurle R, Moschini M, Freschi M, Colombo P, Colecchia M, Ferrari L, Guazzoni G, Conti A, Conti G, Lucianò R, Magnani T, Colombo R. Patriarca C, et al. Among authors: hurle r. Diagn Pathol. 2016 Jan 20;11:6. doi: 10.1186/s13000-016-0466-6. Diagn Pathol. 2016. PMID: 26791567 Free PMC article.
Reply to Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol 2023;6:508-15.
D'Andrea D, Soria F, Hurle R, Enikeev D, Kotov S, Régnier S, Xylinas E, Lusuardi L, Heidenreich A, Cai C, Frego N, Taraktin M, Ryabov M, Gontero P, Compérat E, Shariat SF; eBLOC Study Team. D'Andrea D, et al. Among authors: hurle r. Eur Urol Oncol. 2024 Jun;7(3):639-640. doi: 10.1016/j.euo.2023.10.026. Epub 2023 Nov 17. Eur Urol Oncol. 2024. PMID: 37978025 No abstract available.
Reply to Riccardo Lombardo, Sara Riolo, and Cosimo De Nunzio's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. 2023;6:508-515.
D'Andrea D, Soria F, Hurle R, Enikeev D, Kotov S, Régnier S, Xylinas E, Lusuardi L, Heidenreich A, Cai C, Frego N, Taraktin M, Ryabov M, Gontero P, Compérat E, Shariat SF; eBLOC Study Team. D'Andrea D, et al. Among authors: hurle r. Eur Urol Oncol. 2024 Aug;7(4):967-968. doi: 10.1016/j.euo.2023.10.001. Epub 2023 Oct 19. Eur Urol Oncol. 2024. PMID: 37865570 No abstract available.
Multicenter study on the use of gemcitabine to prevent recurrence of multiple-recurring superficial bladder tumors following intravesical antiblastic agents and/or BCG: evaluation of tolerance.
Morabito F, Rossi R, Graziano ME, Ferrando U, Lancini V, Cretarola E, Conti G, Luporini AC, Muto G, Castelli E, D'Urso L, Razionale P, Lissoni G, Simone M, Francesca F, Sommariva M, Casu M, Hurle R. Morabito F, et al. Among authors: hurle r. Arch Ital Urol Androl. 2006 Mar;78(1):1-4. Arch Ital Urol Androl. 2006. PMID: 16752879 Clinical Trial.
Mast cells as a potential prognostic marker in prostate cancer.
Taverna G, Giusti G, Seveso M, Hurle R, Colombo P, Stifter S, Grizzi F. Taverna G, et al. Among authors: hurle r. Dis Markers. 2013;35(6):711-20. doi: 10.1155/2013/478303. Epub 2013 Nov 11. Dis Markers. 2013. PMID: 24324287 Free PMC article. Review.
The clinical use of statistical permutation test methodology: a tool for identifying predictive variables of outcome.
Racioppi M, Salmaso L, Brombin C, Arboretti R, D'Agostino D, Colombo R, Serretta V, Brausi M, Casetta G, Gontero P, Hurle R, Tenaglia R, Altieri V, Bartoletti R, Maffezzini M, Siracusano S, Morgia G, Bassi PF. Racioppi M, et al. Among authors: hurle r. Urol Int. 2015;94(3):262-9. doi: 10.1159/000365292. Epub 2014 Aug 27. Urol Int. 2015. PMID: 25171377
Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy.
Simone G, Bianchi M, Giannarelli D, Daneshmand S, Papalia R, Ferriero M, Guaglianone S, Sentinelli S, Colombo R, Montorsi F, Collura D, Muto G, Novara G, Hurle R, Rink M, Fisch M, Abol-Enein H, Miranda G, Desai M, Gill I, Gallucci M. Simone G, et al. Among authors: hurle r. World J Urol. 2015 Oct;33(10):1419-28. doi: 10.1007/s00345-014-1465-4. Epub 2014 Dec 27. World J Urol. 2015. PMID: 25542395 Free PMC article.
Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study.
Lughezzani G, Lazzeri M, Buffi NM, Abrate A, Mistretta FA, Hurle R, Pasini L, Castaldo L, Zandegiacomo De Zorzi S, Peschechera R, Fiorini G, Taverna G, Casale P, Guazzoni G. Lughezzani G, et al. Among authors: hurle r. Urol Oncol. 2015 Aug;33(8):337.e7-14. doi: 10.1016/j.urolonc.2015.05.007. Epub 2015 Jun 6. Urol Oncol. 2015. PMID: 26055430
165 results